cbdMD Inc (YCBD)
0.432
-0.03
(-6.09%)
USD |
NYAM |
Nov 05, 16:00
0.432
0.00 (0.00%)
After-Hours: 18:29
cbdMD Profit Margin (Quarterly): 8.89% for June 30, 2024
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
Date | Value |
---|---|
June 30, 2024 | 8.89% |
March 31, 2024 | -68.79% |
December 31, 2023 | -18.54% |
September 30, 2023 | -278.0% |
June 30, 2023 | -28.93% |
March 31, 2023 | -21.42% |
December 31, 2022 | -65.01% |
September 30, 2022 | -186.1% |
June 30, 2022 | -368.1% |
March 31, 2022 | -48.37% |
December 31, 2021 | -205.5% |
September 30, 2021 | -30.90% |
June 30, 2021 | 14.56% |
March 31, 2021 | -106.0% |
December 31, 2020 | -76.21% |
September 30, 2020 | -53.49% |
June 30, 2020 | -84.17% |
Date | Value |
---|---|
March 31, 2020 | |
December 31, 2019 | |
September 30, 2019 | |
June 30, 2019 | -346.0% |
March 31, 2019 | -564.0% |
December 31, 2018 | -453.1% |
September 30, 2018 | 13.67% |
June 30, 2018 | 6.44% |
March 31, 2018 | 45.58% |
December 31, 2017 | -164.7% |
September 30, 2017 | -31.34% |
June 30, 2017 | -11.79% |
March 31, 2017 | -39.42% |
December 31, 2016 | -317.5% |
September 30, 2016 | -448.2% |
June 30, 2016 | -313.0% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-368.1%
Minimum
Jun 2022
14.56%
Maximum
Jun 2021
-95.07%
Average
-65.01%
Median
Dec 2022
Profit Margin (Quarterly) Benchmarks
MariMed Inc | -4.08% |
Flora Growth Corp | -16.77% |
NovaBay Pharmaceuticals Inc | -66.04% |
Palatin Technologies Inc | -2.36K% |
iBio Inc | -4.44K% |
Profit Margin (Quarterly) Related Metrics
Return on Equity | -202.7% |
Return on Assets | -104.8% |
Return on Invested Capital | -186.7% |
Gross Profit Margin (Quarterly) | 65.78% |
Operating Margin (Quarterly) | -7.38% |
Return on Net Operating Assets | -133.1% |